Abstract:ABSTRACT Few data are available on the lung microbiota composition of patients with coronavirus disease 2019-related acute respiratory distress syndrome (C-ARDS) receiving invasive mechanical ventilation (IMV). Moreover, it has never been investigated whether there is a potential correlation between lung microbiota communities and respiratory mechanics. We performed a prospective observational study in two intensive care units of a university hospital in Italy. Lung microbiota was investigated by bacterial 16S rRNA gene sequencing, performed on bronchoalveolar lavage fluid samples withdrawn after intubation. The lung bacterial communities were analyzed after stratification by respiratory system compliance/predicted body weight (Crs) and ventilatory ratio (VR). Weaning from IMV and hospital survival were assessed as secondary outcomes. In 70 C-ARDS patients requiring IMV from 1 April through 31 December 2020, the lung microbiota composition (phylum taxonomic level, permutational multivariate analysis of variance test) significantly differed between who had low Crs vs those with high Crs ( P = 0.010), as well as in patients with low VR vs high VR ( P = 0.012). As difference-driving taxa, Proteobacteria ( P = 0.017) were more dominant and Firmicutes ( P = 0.040) were less dominant in low- vs high-Crs patients. Similarly, Proteobacteria were more dominant in low- vs high-VR patients ( P = 0.013). After multivariable regression analysis, we further observed lung microbiota diversity as a negative predictor of weaning from IMV and hospital survival (hazard ratio = 3.31; 95% confidence interval, 1.52–7.20, P = 0.048). C-ARDS patients with low Crs/low VR had a Proteobacteria-dominated lung microbiota. Whether patients with a more diverse lung bacterial community may have more chances to be weaned from IMV and discharged alive from the hospital warrants further large-scale investigations. IMPORTANCE Lung microbiota characteristics were demonstrated to predict ventilator-free days and weaning from mechanical ventilation in patients with acute respiratory distress syndrome (ARDS). In this study, we observed that in severe coronavirus disease 2019 patients with ARDS who require invasive mechanical ventilation, lung microbiota characteristics were associated with respiratory mechanics. Specifically, the lung microbiota of patients with low respiratory system compliance and low ventilatory ratio was characterized by Proteobacteria dominance. Moreover, after multivariable regression analysis, we also found an association between patients’ microbiota diversity and a higher possibility of being weaned from mechanical ventilation and discharged alive from the hospital. For these reasons, lung microbiota characterization may help to stratify patient characteristics and orient the delivery of target interventions. (This study has been registered at ClinicalTrials.gov on 17 February 2020 under identifier NCT04271345.) Clinical Trial Registered at ClinicalTrials.gov, 17 February 2020 ( NCT04271345 ).

Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support

Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study

Outcomes of noninvasive ventilation as the ceiling of treatment in patients with COVID-19

Long term outcome in patients treated with veno-venous extracorporeal membrane oxygenation: A prospective observational study

Assessment of respiratory support decision and the outcome of invasive mechanical ventilation in severe COVID-19 with ARDS

Impact of ventilatory support modalities and timing of intubation on longitudinal recovery of pulmonary sequelae in critically ill Covid-19 patients

Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness

Comprehensive rehabilitation treatment for sub-acute COVID-19 patients: an observational study

COVID-19 after 2 Years from Hospital Discharge: A Pulmonary Function and Chest Computed Tomography Follow-Up Study

Long-term consequences in Covid-19 and Non-Covid-19 patients survivors of critical illness. A descriptive study

Lung microbiota composition, respiratory mechanics, and outcomes in COVID-19-related ARDS

Noninvasive ventilation in COVID-19 patients aged ≥ 70 years-a prospective multicentre cohort study

Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study

Surviving Critical Care: A Follow-Up Study Assessing Pulmonary Function, Cardiopulmonary Exercise Testing, and Quality of Life in COVID-19-Affected Patients

Clinical and functional status of patients with severe COVID-19 pneumonia: an observational study at 2-3 months following discharge

Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS

Short-Term Consequences of SARS-CoV-2-Related Pneumonia: A Follow Up Study

One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients

Persistent disabilities 28 months after COVID-19 hospitalisation, a prospective cohort study

Long-term changes in pulmonary function among patients surviving to COVID-19 pneumonia

Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study